Search
![](https://static.wixstatic.com/media/nsplsh_4c6e764345585177432d6f~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_4c6e764345585177432d6f~mv2.jpg)
![USFDA Guidance: Real-Time Oncology Review (RTOR)](https://static.wixstatic.com/media/nsplsh_4c6e764345585177432d6f~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_4c6e764345585177432d6f~mv2.jpg)
Sharan Murugan
- Nov 11, 2023
- 2 min
USFDA Guidance: Real-Time Oncology Review (RTOR)
The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) released guidance earlier this week (07 November 2023)...
19 views0 comments
![](https://static.wixstatic.com/media/6516fb_37ce9e13afe6449b9bc53099d4e06ac5~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,lg_1,q_30,blur_30,enc_auto/6516fb_37ce9e13afe6449b9bc53099d4e06ac5~mv2.jpg)
![Philippines FDA - Guidelines on Abridged and Verification Review Pathways for New Drug Registration](https://static.wixstatic.com/media/6516fb_37ce9e13afe6449b9bc53099d4e06ac5~mv2.jpg/v1/fill/w_399,h_232,fp_0.50_0.50,q_90,enc_auto/6516fb_37ce9e13afe6449b9bc53099d4e06ac5~mv2.jpg)
Sharan Murugan
- Jun 18, 2022
- 1 min
Philippines FDA - Guidelines on Abridged and Verification Review Pathways for New Drug Registration
Abridged review refers to a limited independent assessment of specific parts of the dossier, or submission for suitability of use under...
92 views0 comments